Information Provided By: 
Fly News Breaks for September 11, 2017
ALGN
Sep 11, 2017 | 05:39 EDT
Piper Jaffray analyst Matt O'Brien raised his price target for Align Technology to $200 after attending the Invisalign GP Summit this past weekend. The analyst left the meeting feeling the company's iTero is much more vital to the general practitioner workflow than previously thought and that moving teeth is growing into an increasingly important piece of the GP practice. He calls Align a "one of a kind" name and tells investors to build positions at current levels. O'Brien keeps an Overweight rating on the shares.
News For ALGN From the Last 2 Days
ALGN
Apr 18, 2024 | 07:23 EDT
Stifel raised the firm's price target on Align Technology to $400 from $350 and keeps a Buy rating on the shares. Respondents to the firm's survey point to "solid" 2024 year-over-year case volume growth and while Invisalign's share is expected to step down "modestly" year-over-year, new product feedback is upbeat, says the firm, which adds that it has "an upside bias to our 2024 revenue estimate."
